.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Argus Health
McKesson
Medtronic
Teva
Chubb
Covington
Chinese Patent Office
Baxter

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010515

« Back to Dashboard
NDA 010515 describes ISUPREL, which is a drug marketed by Hospira and Sanofi Aventis Us and is included in four NDAs. It is available from three suppliers. Additional details are available on the ISUPREL profile page.

The generic ingredient in ISUPREL is isoproterenol hydrochloride. There are fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.

Summary for 010515

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 010515

Mechanism of ActionAdrenergic beta-Agonists

Suppliers and Packaging for NDA: 010515

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISUPREL
isoproterenol hydrochloride
INJECTABLE;INJECTION 010515 NDA Valeant Pharmaceuticals North America LLC 0187-4330 0187-4330-01 25 AMPULE in 1 CARTON (0187-4330-01) > 1 mL in 1 AMPULE
ISUPREL
isoproterenol hydrochloride
INJECTABLE;INJECTION 010515 NDA Valeant Pharmaceuticals North America LLC 0187-4330 0187-4330-05 10 AMPULE in 1 CARTON (0187-4330-05) > 5 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.2MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Novartis
Express Scripts
Moodys
Julphar
Teva
Boehringer Ingelheim
Medtronic
Mallinckrodt
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot